Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1974 Jun;5(6):582–588. doi: 10.1128/aac.5.6.582

Mechanism of Silver Sulfadiazine Action on Burn Wound Infections

Charles L Fox Jr 1,2, Shanta M Modak 1,2
PMCID: PMC429018  PMID: 15825409

Abstract

The role of silver and sulfadiazine in the mechanism of action of silver sulfadiazine on burn wound infections was investigated. Silver, but not sulfadiazine, was bound by bacteria. Sulfadiazine did not act as an antibacterial agent in low concentrations, but exhibited specific synergism in combination with subinhibitory levels of silver sulfadiazine. The efficacy of silver sulfadiazine is thought to result from its slow and steady reactions with serum and other sodium chloride-containing body fluids, which permits the slow and sustained delivery of silver ions into the wound environs. In this circumstance, a relatively minute amount of sulfadiazine appears active.

Full text

PDF
582

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carr H. S., Wlodkowski T. J., Rosenkranz H. S. Silver sulfadiazine: in vitro antibacterial activity. Antimicrob Agents Chemother. 1973 Nov;4(5):585–587. doi: 10.1128/aac.4.5.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dickinson S. J. Topical therapy of burns in children with silver sulfadiazine. N Y State J Med. 1973 Aug 15;73(16):2045–2049. [PubMed] [Google Scholar]
  4. Fox C. L., Jr, Rappole B. W., Stanford W. Control of pseudomonas infection in burns by silver sulfadiazine. Surg Gynecol Obstet. 1969 May;128(5):1021–1026. [PubMed] [Google Scholar]
  5. Fox C. L., Jr, Sampath A. C., Stanford J. W. Virulence of Pseudomonas infection in burned rats and mice. Comparative efficacy of silver sulfadiazine and mafenide. Arch Surg. 1970 Oct;101(4):508–512. doi: 10.1001/archsurg.1970.01340280060015. [DOI] [PubMed] [Google Scholar]
  6. Fox C. L., Jr Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg. 1968 Feb;96(2):184–188. doi: 10.1001/archsurg.1968.01330200022004. [DOI] [PubMed] [Google Scholar]
  7. Lowbury E. J., Jackson D. M., Ricketts C. R., Davis B. Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim. Injury. 1971 Jul;3(1):18–24. doi: 10.1016/s0020-1383(71)80131-6. [DOI] [PubMed] [Google Scholar]
  8. Lowbury E. J., Lilly H. A., Cason J. S., Jackson D. M., Bull J. P., Davies J. W., Ford P. M. Alternative forms of local treatment for burns. Lancet. 1971 Nov 20;2(7734):1105–1111. doi: 10.1016/s0140-6736(71)91269-4. [DOI] [PubMed] [Google Scholar]
  9. McDougall I. A. Burns and the use of silver sulphadiazine. Aust N Z J Surg. 1972 Nov;42(2):174–178. doi: 10.1111/j.1445-2197.1972.tb06772.x. [DOI] [PubMed] [Google Scholar]
  10. Modak S. M., Fox C. L., Jr Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol. 1973 Oct 1;22(19):2391–2404. doi: 10.1016/0006-2952(73)90341-9. [DOI] [PubMed] [Google Scholar]
  11. Ricketts C. R., Lowbury E. J., Lawrence J. C., Hall M., Wilkins M. D. Mechanism of prophylaxis by silver compounds against infection of burns. Br Med J. 1970 May 23;1(5707):444–446. doi: 10.1136/bmj.2.5707.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rosenkranz H. S., Carr H. S. Silver sulfadiazine: effect on the growth and metabolism of bacteria. Antimicrob Agents Chemother. 1972 Nov;2(5):367–372. doi: 10.1128/aac.2.5.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rosenkranz H. S., Rosenkranz S. Silver sulfadiazine: interaction with isolated deoxyribonucleic acid. Antimicrob Agents Chemother. 1972 Nov;2(5):373–383. doi: 10.1128/aac.2.5.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Stanford W., Rappole B. W., Fox C. L., Jr Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns. J Trauma. 1969 May;9(5):377–388. doi: 10.1097/00005373-196905000-00002. [DOI] [PubMed] [Google Scholar]
  15. Withers J. N. Control of pseudomonas infections in burns with silver sulfadiazine. Hawaii Med J. 1970 Mar-Apr;29(4):298–300. [PubMed] [Google Scholar]
  16. Wlodkowski T. J., Rosenkranz H. S. Antifungal activity of silver sulphadiazine. Lancet. 1973 Sep 29;2(7831):739–740. doi: 10.1016/s0140-6736(73)92576-2. [DOI] [PubMed] [Google Scholar]
  17. Wysor M. S., Zollinhofer R. E. On the mode of action of silver sulfadiazine. Pathol Microbiol (Basel) 1972;38(4):296–308. doi: 10.1159/000162423. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES